Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti‐TNF‐alpha therapy for Crohn's disease
Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti‐TNF‐alpha therapy for Crohn's disease
T. Sipponen,E. Savilahti,4 Authors,M. Färkkilä
2008 · DOI: 10.1002/ibd.20490
Inflammatory Bowel Diseases · 245 Citations
TLDR
Concentrations of fecal calprotectin and lactoferrin after the anti‐TNF‐&agr; treatment were significantly lower and these fecal neutrophil‐derived proteins may thus be useful surrogate markers for mucosal healing.
